Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction

The utility of contrast MRI for assessing myocardial viability in stable coronary artery disease (CAD) with left ventricular dysfunction is uncertain. We therefore performed cine and contrast MRI in 24 stable patients with CAD and regional contractile abnormalities and compared MRI findings with res...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 1998-12, Vol.98 (24), p.2687-2694
Hauptverfasser: RAMANI, K, JUDD, R. M, HOLLY, T. A, PARRISH, T. B, RIGOLIN, V. H, PARKER, M. A, CALLAHAN, C, FITZGERALD, S. W, BONOW, R. O, KLOCKE, F. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2694
container_issue 24
container_start_page 2687
container_title Circulation (New York, N.Y.)
container_volume 98
creator RAMANI, K
JUDD, R. M
HOLLY, T. A
PARRISH, T. B
RIGOLIN, V. H
PARKER, M. A
CALLAHAN, C
FITZGERALD, S. W
BONOW, R. O
KLOCKE, F. J
description The utility of contrast MRI for assessing myocardial viability in stable coronary artery disease (CAD) with left ventricular dysfunction is uncertain. We therefore performed cine and contrast MRI in 24 stable patients with CAD and regional contractile abnormalities and compared MRI findings with rest-redistribution 201Tl imaging and dobutamine echocardiography. Delayed MRI contrast enhancement patterns were examined from 3 to 15 minutes after injection of 0.1 mmol/kg IV gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). Comparable MRI and 201Tl basal and midventricular short-axis images were subdivided into 6 segments. Segments judged nonviable by quantitative and qualitative assessment of 201Tl scans showed persistent, systematically greater MRI contrast signal intensity than segments judged viable (P
doi_str_mv 10.1161/01.CIR.98.24.2687
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70118309</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70118309</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-d2f09edbe91f85f328add53055d4dc3a16e8ee912873878d8cde575c02a9ac6b3</originalsourceid><addsrcrecordid>eNpdkd2KFDEQhYMo67j6AF4IQcS7bvPT6U5fyuDPwoIgeh3SSfVulp5kTKV36ZfxWc2wg4JXRdX5ziHkEPKas5bznn9gvN1ffW9H3YquFb0enpAdV6JrOiXHp2THGBubQQrxnLxAvKtrLwd1QS5Grfiouh35vU-xZIuFHuxNhBIczYAp2uiAhnoL8YaGSMstUIsIiAeIhaaZHrbkbPbBLvQ-2CksoWwn8mhLqAjSh1BuKRY7LUBdyjUzb9TmAnX4gGCxRkZPF5gLva-WHNy62Ez9hvMaXQkpviTPZrsgvDrPS_Lz86cf-6_N9bcvV_uP143r5FAaL2Y2gp9g5LNWsxTaeq8kU8p33knLe9BQRaEHqQfttfOgBuWYsKN1_SQvyfvH3GNOv1bAYg4BHSyLjZBWNAPjXEs2VvDtf-BdWnOsbzOCi75nQukK8UfI5YSYYTbHXP8yb4YzcyrOMG5qcWbURnTmVFz1vDkHr9MB_F_HuamqvzvrFp1d5lwbCvgvuOeDEkr-AZfbpRk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212660258</pqid></control><display><type>article</type><title>Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Journals@Ovid Complete</source><creator>RAMANI, K ; JUDD, R. M ; HOLLY, T. A ; PARRISH, T. B ; RIGOLIN, V. H ; PARKER, M. A ; CALLAHAN, C ; FITZGERALD, S. W ; BONOW, R. O ; KLOCKE, F. J</creator><creatorcontrib>RAMANI, K ; JUDD, R. M ; HOLLY, T. A ; PARRISH, T. B ; RIGOLIN, V. H ; PARKER, M. A ; CALLAHAN, C ; FITZGERALD, S. W ; BONOW, R. O ; KLOCKE, F. J</creatorcontrib><description>The utility of contrast MRI for assessing myocardial viability in stable coronary artery disease (CAD) with left ventricular dysfunction is uncertain. We therefore performed cine and contrast MRI in 24 stable patients with CAD and regional contractile abnormalities and compared MRI findings with rest-redistribution 201Tl imaging and dobutamine echocardiography. Delayed MRI contrast enhancement patterns were examined from 3 to 15 minutes after injection of 0.1 mmol/kg IV gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). Comparable MRI and 201Tl basal and midventricular short-axis images were subdivided into 6 segments. Segments judged nonviable by quantitative and qualitative assessment of 201Tl scans showed persistent, systematically greater MRI contrast signal intensity than segments judged viable (P&lt;/=0.002). Delayed contrast hyperenhancement also occurred in segments judged nonviable by dobutamine echocardiography (P&lt;/=0.03). The presence or absence of hyperenhancement correlated most closely with nonviability and viability, respectively, in segments that were akinetic or dyskinetic under resting conditions (83% concordance with 201Tl in both cases). In segments with resting hypokinesis, 58% of segments showing hyperenhancement were judged viable by 201Tl and may have represented an admixture of scar tissue and viable myocardium. Delayed (by 3 to 15 minutes) hyperenhancement of Gd-DTPA contrast-enhanced MRI images occurs frequently in dysfunctional areas of the left ventricle in patients with stable CAD. Hyperenhancement is associated with nonviability by rest-redistribution 201Tl scintigraphy and dobutamine echocardiography, particularly in regions exhibiting resting akinesis/dyskinesis. The absence of hyperenhancement correlates with radionuclide and echocardiographic determinations of viability, regardless of resting contractile function.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.CIR.98.24.2687</identifier><identifier>PMID: 9851954</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Cardiomyopathies - diagnosis ; Cardiomyopathies - diagnostic imaging ; Cardiovascular system ; Contrast Media ; Coronary Disease - diagnosis ; Coronary Disease - diagnostic imaging ; Dobutamine ; Female ; Gadolinium DTPA ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Magnetic Resonance Imaging - methods ; Male ; Medical sciences ; Middle Aged ; Myocardial Contraction - physiology ; Polylysine ; Radiodiagnosis. Nmr imagery. Nmr spectrometry ; Thallium Radioisotopes ; Tomography, Emission-Computed, Single-Photon ; Ultrasonography ; Ventricular Dysfunction, Left - diagnosis ; Ventricular Dysfunction, Left - diagnostic imaging</subject><ispartof>Circulation (New York, N.Y.), 1998-12, Vol.98 (24), p.2687-2694</ispartof><rights>1999 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Dec 15, 1998</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-d2f09edbe91f85f328add53055d4dc3a16e8ee912873878d8cde575c02a9ac6b3</citedby><cites>FETCH-LOGICAL-c437t-d2f09edbe91f85f328add53055d4dc3a16e8ee912873878d8cde575c02a9ac6b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1617525$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9851954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RAMANI, K</creatorcontrib><creatorcontrib>JUDD, R. M</creatorcontrib><creatorcontrib>HOLLY, T. A</creatorcontrib><creatorcontrib>PARRISH, T. B</creatorcontrib><creatorcontrib>RIGOLIN, V. H</creatorcontrib><creatorcontrib>PARKER, M. A</creatorcontrib><creatorcontrib>CALLAHAN, C</creatorcontrib><creatorcontrib>FITZGERALD, S. W</creatorcontrib><creatorcontrib>BONOW, R. O</creatorcontrib><creatorcontrib>KLOCKE, F. J</creatorcontrib><title>Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>The utility of contrast MRI for assessing myocardial viability in stable coronary artery disease (CAD) with left ventricular dysfunction is uncertain. We therefore performed cine and contrast MRI in 24 stable patients with CAD and regional contractile abnormalities and compared MRI findings with rest-redistribution 201Tl imaging and dobutamine echocardiography. Delayed MRI contrast enhancement patterns were examined from 3 to 15 minutes after injection of 0.1 mmol/kg IV gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). Comparable MRI and 201Tl basal and midventricular short-axis images were subdivided into 6 segments. Segments judged nonviable by quantitative and qualitative assessment of 201Tl scans showed persistent, systematically greater MRI contrast signal intensity than segments judged viable (P&lt;/=0.002). Delayed contrast hyperenhancement also occurred in segments judged nonviable by dobutamine echocardiography (P&lt;/=0.03). The presence or absence of hyperenhancement correlated most closely with nonviability and viability, respectively, in segments that were akinetic or dyskinetic under resting conditions (83% concordance with 201Tl in both cases). In segments with resting hypokinesis, 58% of segments showing hyperenhancement were judged viable by 201Tl and may have represented an admixture of scar tissue and viable myocardium. Delayed (by 3 to 15 minutes) hyperenhancement of Gd-DTPA contrast-enhanced MRI images occurs frequently in dysfunctional areas of the left ventricle in patients with stable CAD. Hyperenhancement is associated with nonviability by rest-redistribution 201Tl scintigraphy and dobutamine echocardiography, particularly in regions exhibiting resting akinesis/dyskinesis. The absence of hyperenhancement correlates with radionuclide and echocardiographic determinations of viability, regardless of resting contractile function.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cardiomyopathies - diagnosis</subject><subject>Cardiomyopathies - diagnostic imaging</subject><subject>Cardiovascular system</subject><subject>Contrast Media</subject><subject>Coronary Disease - diagnosis</subject><subject>Coronary Disease - diagnostic imaging</subject><subject>Dobutamine</subject><subject>Female</subject><subject>Gadolinium DTPA</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Contraction - physiology</subject><subject>Polylysine</subject><subject>Radiodiagnosis. Nmr imagery. Nmr spectrometry</subject><subject>Thallium Radioisotopes</subject><subject>Tomography, Emission-Computed, Single-Photon</subject><subject>Ultrasonography</subject><subject>Ventricular Dysfunction, Left - diagnosis</subject><subject>Ventricular Dysfunction, Left - diagnostic imaging</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkd2KFDEQhYMo67j6AF4IQcS7bvPT6U5fyuDPwoIgeh3SSfVulp5kTKV36ZfxWc2wg4JXRdX5ziHkEPKas5bznn9gvN1ffW9H3YquFb0enpAdV6JrOiXHp2THGBubQQrxnLxAvKtrLwd1QS5Grfiouh35vU-xZIuFHuxNhBIczYAp2uiAhnoL8YaGSMstUIsIiAeIhaaZHrbkbPbBLvQ-2CksoWwn8mhLqAjSh1BuKRY7LUBdyjUzb9TmAnX4gGCxRkZPF5gLva-WHNy62Ez9hvMaXQkpviTPZrsgvDrPS_Lz86cf-6_N9bcvV_uP143r5FAaL2Y2gp9g5LNWsxTaeq8kU8p33knLe9BQRaEHqQfttfOgBuWYsKN1_SQvyfvH3GNOv1bAYg4BHSyLjZBWNAPjXEs2VvDtf-BdWnOsbzOCi75nQukK8UfI5YSYYTbHXP8yb4YzcyrOMG5qcWbURnTmVFz1vDkHr9MB_F_HuamqvzvrFp1d5lwbCvgvuOeDEkr-AZfbpRk</recordid><startdate>19981215</startdate><enddate>19981215</enddate><creator>RAMANI, K</creator><creator>JUDD, R. M</creator><creator>HOLLY, T. A</creator><creator>PARRISH, T. B</creator><creator>RIGOLIN, V. H</creator><creator>PARKER, M. A</creator><creator>CALLAHAN, C</creator><creator>FITZGERALD, S. W</creator><creator>BONOW, R. O</creator><creator>KLOCKE, F. J</creator><general>Lippincott Williams &amp; Wilkins</general><general>American Heart Association, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>19981215</creationdate><title>Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction</title><author>RAMANI, K ; JUDD, R. M ; HOLLY, T. A ; PARRISH, T. B ; RIGOLIN, V. H ; PARKER, M. A ; CALLAHAN, C ; FITZGERALD, S. W ; BONOW, R. O ; KLOCKE, F. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-d2f09edbe91f85f328add53055d4dc3a16e8ee912873878d8cde575c02a9ac6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cardiomyopathies - diagnosis</topic><topic>Cardiomyopathies - diagnostic imaging</topic><topic>Cardiovascular system</topic><topic>Contrast Media</topic><topic>Coronary Disease - diagnosis</topic><topic>Coronary Disease - diagnostic imaging</topic><topic>Dobutamine</topic><topic>Female</topic><topic>Gadolinium DTPA</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Contraction - physiology</topic><topic>Polylysine</topic><topic>Radiodiagnosis. Nmr imagery. Nmr spectrometry</topic><topic>Thallium Radioisotopes</topic><topic>Tomography, Emission-Computed, Single-Photon</topic><topic>Ultrasonography</topic><topic>Ventricular Dysfunction, Left - diagnosis</topic><topic>Ventricular Dysfunction, Left - diagnostic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RAMANI, K</creatorcontrib><creatorcontrib>JUDD, R. M</creatorcontrib><creatorcontrib>HOLLY, T. A</creatorcontrib><creatorcontrib>PARRISH, T. B</creatorcontrib><creatorcontrib>RIGOLIN, V. H</creatorcontrib><creatorcontrib>PARKER, M. A</creatorcontrib><creatorcontrib>CALLAHAN, C</creatorcontrib><creatorcontrib>FITZGERALD, S. W</creatorcontrib><creatorcontrib>BONOW, R. O</creatorcontrib><creatorcontrib>KLOCKE, F. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RAMANI, K</au><au>JUDD, R. M</au><au>HOLLY, T. A</au><au>PARRISH, T. B</au><au>RIGOLIN, V. H</au><au>PARKER, M. A</au><au>CALLAHAN, C</au><au>FITZGERALD, S. W</au><au>BONOW, R. O</au><au>KLOCKE, F. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>1998-12-15</date><risdate>1998</risdate><volume>98</volume><issue>24</issue><spage>2687</spage><epage>2694</epage><pages>2687-2694</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>The utility of contrast MRI for assessing myocardial viability in stable coronary artery disease (CAD) with left ventricular dysfunction is uncertain. We therefore performed cine and contrast MRI in 24 stable patients with CAD and regional contractile abnormalities and compared MRI findings with rest-redistribution 201Tl imaging and dobutamine echocardiography. Delayed MRI contrast enhancement patterns were examined from 3 to 15 minutes after injection of 0.1 mmol/kg IV gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). Comparable MRI and 201Tl basal and midventricular short-axis images were subdivided into 6 segments. Segments judged nonviable by quantitative and qualitative assessment of 201Tl scans showed persistent, systematically greater MRI contrast signal intensity than segments judged viable (P&lt;/=0.002). Delayed contrast hyperenhancement also occurred in segments judged nonviable by dobutamine echocardiography (P&lt;/=0.03). The presence or absence of hyperenhancement correlated most closely with nonviability and viability, respectively, in segments that were akinetic or dyskinetic under resting conditions (83% concordance with 201Tl in both cases). In segments with resting hypokinesis, 58% of segments showing hyperenhancement were judged viable by 201Tl and may have represented an admixture of scar tissue and viable myocardium. Delayed (by 3 to 15 minutes) hyperenhancement of Gd-DTPA contrast-enhanced MRI images occurs frequently in dysfunctional areas of the left ventricle in patients with stable CAD. Hyperenhancement is associated with nonviability by rest-redistribution 201Tl scintigraphy and dobutamine echocardiography, particularly in regions exhibiting resting akinesis/dyskinesis. The absence of hyperenhancement correlates with radionuclide and echocardiographic determinations of viability, regardless of resting contractile function.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>9851954</pmid><doi>10.1161/01.CIR.98.24.2687</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 1998-12, Vol.98 (24), p.2687-2694
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_70118309
source MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals; Journals@Ovid Complete
subjects Adult
Aged
Biological and medical sciences
Cardiomyopathies - diagnosis
Cardiomyopathies - diagnostic imaging
Cardiovascular system
Contrast Media
Coronary Disease - diagnosis
Coronary Disease - diagnostic imaging
Dobutamine
Female
Gadolinium DTPA
Humans
Investigative techniques, diagnostic techniques (general aspects)
Magnetic Resonance Imaging - methods
Male
Medical sciences
Middle Aged
Myocardial Contraction - physiology
Polylysine
Radiodiagnosis. Nmr imagery. Nmr spectrometry
Thallium Radioisotopes
Tomography, Emission-Computed, Single-Photon
Ultrasonography
Ventricular Dysfunction, Left - diagnosis
Ventricular Dysfunction, Left - diagnostic imaging
title Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A12%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contrast%20magnetic%20resonance%20imaging%20in%20the%20assessment%20of%20myocardial%20viability%20in%20patients%20with%20stable%20coronary%20artery%20disease%20and%20left%20ventricular%20dysfunction&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=RAMANI,%20K&rft.date=1998-12-15&rft.volume=98&rft.issue=24&rft.spage=2687&rft.epage=2694&rft.pages=2687-2694&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.CIR.98.24.2687&rft_dat=%3Cproquest_cross%3E70118309%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=212660258&rft_id=info:pmid/9851954&rfr_iscdi=true